What Gelaspan 4% Treats: Main Uses and Benefits

Gelaspan 4% is primarily relevant for managing acute deficits in circulatory volume and supporting the stability of low blood pressure. In therapeutic contexts, it is commonly used to help manage the condition of hypovolaemia.

This solution is applied across conditions marked by increased physiological stress, such as those sustained during major traumatic injuries, extensive burn injuries, or significant blood loss during a surgical operation. The medication is relevant for easing severe symptomatic patterns that accompany critical volume loss, including haemodynamic instability and the state of shock. It is used to help stabilize symptom clusters, like dangerously low hypotension.

Therapeutic use of this medication may include support for conditions such as relative or absolute hypovolaemia, the management of shock resulting from blood or body fluid loss, and the support of treatment and prophylaxis related to hypotension.

---

“The primary benefit involves supportive fluid volume management that assists with addressing acute deficits during episodes of heightened physiological stress.”

---

Quick Fact: Support for Haemodynamic Instability Gelaspan 4% contributes to maintaining systemic pressure and supports tissue oxygen delivery, assisting with functional stability during difficult acute episodes.

Regulatory References

1. Summary of Product Characteristics (SmPC) from the HPRA

Population Eligibility and Contraindications

The eligibility profile for Gelaspan 4% is defined by strict regulatory criteria, specifying who is permitted to use the solution and who is absolutely prohibited.

Absolute Contraindications (Who Must Not Use)

Use is prohibited for patients with:

• Known hypersensitivity to the active substance, succinylated gelatin, or any of the excipients.
• Hypersensitivity to the alpha-Gal allergen, including a known allergy to red meat (mammalian meat) and offal.
• Pre-existing conditions, including Hypervolaemia (elevated plasma volumes), Hyperhydration, and high blood potassium levels (Hyperkalaemia).
• Severe organ compromise such as Severe heart failure (e.g., acute congestive cardiac failure) or Severe renal failure.

Restricted and Conditional Use

The medicine is primarily intended for adults. However, the regulatory label requires specific caution for certain groups:

• Children (Paediatric population): Use is conditional as safety and efficacy are not yet completely established. It is restricted to circumstances where the expected benefits clearly outweigh the potential risks.
• Pregnant Women: Use is restricted to emergency situations and is only administered if the potential clinical benefit is greater than the foetal risk.
• Elderly Patients and those with severely impaired renal function or conditions at risk of circulatory overload (e.g., hypertension or pulmonary oedema) require special caution and careful monitoring.

The interaction profile of Gelaspan 4% is defined by its colloidal nature and balanced electrolyte composition, which requires specific constraints regarding co-administered medicinal products and diagnostic procedures.

Interaction Category	Interacting Agents and Official Description
Potassium and Cardiac Agents	Co-administration with agents that increase serum potassium, such as ACE inhibitors, potassium-sparing diuretics, Cyclosporine, Tacrolimus, and certain NSAIDs, may increase the risk of severe hyperkalaemia and cardiac arrhythmia. The potassium content of the solution is documented to reduce the therapeutic effect of cardiac glycosides.
Sodium and Fluid Balance	Caution is required with medicines that cause sodium retention, including corticosteroids and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), as this combination may lead to oedema. Separately, ACTH, corticosteroids, and loop diuretics may increase the renal elimination of potassium.
Administration Separation	Gelaspan 4% must not be infused through the same infusion line as blood or blood products (including packed cells and plasma fractions); two separate infusion systems are required for co-administration.
Laboratory Test Interference	The solution is documented to interfere with specific clinical-chemical tests, potentially leading to falsely high values for the erythrocyte sedimentation rate, the specific gravity of urine, and various unspecific protein assays (e.g., the biuret method).

The official regulatory classification requires specific management for these interactions, emphasizing the potential for additive electrolyte effects and mandatory procedural constraints for intravenous co-administration.

How Gelaspan 4% Works

---

Colloidal Volume Expansion

Gelaspan 4% is a macromolecular colloid that targets the intravascular compartment. Due to its molecular weight and physiochemical properties, the succinylated gelatin restricts its distribution to the circulatory system, where it exerts a significant colloid-osmotic pressure gradient. This physicochemical interaction modulates transcapillary fluid dynamics, initiating the net movement of water from the interstitial space into the vasculature. The resulting downstream cascade is an increase in circulating volume, leading to predictable modification of hemodynamic parameters such as central venous pressure and cardiac output, strictly within the physiological domain.

---

Electrolyte and Acid-Base Modification

The solution's composition, containing electrolytes at concentrations comparable to plasma, influences systemic fluid and electrolyte homeostasis. Specifically, the chloride concentration affects the ratio of strong ions, thereby modulating acid-base status. This mechanistic profile acts to maintain the pre-existing electrolyte balance, preventing the development of concentration imbalances (e.g., hyperchloremia) and supporting the intrinsic regulation of physiological pH within the circulatory system.

How to Use Gelaspan 4%

Gelaspan 4% is an intravenous solution (IV) intended strictly for fluid replacement and is administered solely in a clinical or hospital environment under medical supervision. The usage pattern is highly dependent on the patient's individual needs for circulatory volume restoration.

---

Official Administration Protocol

Usage Constraint	Standard Instruction
Route of Administration	Intravenous Infusion only.
Standard Adult Dose	Typically 500 ml to 1000 ml initially, with continuous adjustment based on fluid loss.
Maximum Dose	Limited by the risk of excessive blood thinning (haemodilution), generally to prevent the haematocrit level from falling below 25% to 30%.
Initial Infusion Rate	The first 20 ml to 30 ml must be infused slowly.
Acute Infusion Rate	In shock or emergency situations, 500 ml can be infused rapidly within 5 to 10 minutes.
Warming Requirement	Should be warmed to no more than 37 C if given rapidly by pressure infusion.

---

Population and Procedural Constraints

The frequency of use is as-needed, determined by the patient's acute volume loss and continuous haemodynamic monitoring. The solution must not be infused through the same line as blood or blood products; separate infusion systems are required for co-administration. For children over 25 kg, 500 ml is administered at an appropriate rate, though the dose must be determined especially carefully due to limited experience in the pediatric population.

Gelaspan 4%: Recent Clinical Evidence

Gelaspan 4% is a colloidal plasma volume substitute (succinylated gelatin) in a balanced electrolyte solution, primarily investigated for restoring blood volume in patients with absolute or relative hypovolemia (low blood volume) and shock. Its mechanism involves increasing oncotic pressure in the blood vessels, which helps retain water and expand circulating plasma volume.

---

Efficacy and Comparison Studies

Research has focused on Gelaspan 4%'s role in fluid resuscitation, particularly in surgical and critically ill patients. Key findings from randomized controlled trials (RCTs) include:

• Volume Expansion: Studies confirm that the compound is associated with plasma volume expansion. However, a consensus is still developing regarding the superiority of gelatin solutions over crystalloid solutions (like Ringer's acetate) alone for rapid hemodynamic stability (HDS) in critical care settings, such as sepsis.
• Fluid Balance: In some trials involving septic patients, a gelatin-based regimen was observed to lead to a more favorable fluid balance and less fluid overload at 24 hours compared to crystalloid regimens, though the time to achieve HDS did not significantly differ between the groups.
• Surgical Use: Research evaluating its use as a pre-loading fluid before spinal anesthesia for certain surgeries found that it, like other colloids tested, did not significantly prevent post-anesthesia hypotension.

---

Safety and Risk Factors

Clinical evidence regarding Gelaspan 4% generally describes its profile as safe for use in volume resuscitation in specific enrolled patient populations. However, as a colloid, potential risks related to dilution effects (e.g., on coagulation factors and hematocrit) and the risk of anaphylactoid reactions (allergic reactions) are noted across trials. It is contraindicated in conditions such as hypervolemia, hyperhydration, severe cardiac insufficiency, and known allergy to gelatin.

Common questions about Gelaspan 4% (FAQ)

Q: How quickly does Gelaspan 4% start to work?

Regulatory documents indicate that once the infusion is administered, the solution is rapidly distributed throughout the bloodstream. This rapid distribution allows it to begin its intended function: retaining fluid and supporting the circulating volume.

---

Q: What is the risk of fluid overload with Gelaspan 4%?

The official safety information emphasizes that volume overload—or hypervolaemia—must be strictly avoided, as it can be a risk if the product is administered too quickly or in excessive amounts. For this reason, the dosage is subject to careful adjustment and monitoring by a healthcare professional, especially in patients who have pre-existing heart or lung conditions.

---

Q: What happens if too much Gelaspan 4% is given?

Official product information notes that if too much Gelaspan 4% is administered, it may lead to circulatory overload, which means excess fluid in the body's vascular system. It may also cause undesirable changes to the body’s salt (electrolyte) levels, requiring careful clinical management.

---

Q: Can Gelaspan 4% be used for non-bleeding causes of low volume?

Regulatory documents indicate that this medicine is used for the treatment of both relative and absolute hypovolaemia, which is a state of low circulating volume, and for various forms of shock. The indication is for volume restoration in general, and is not strictly limited to blood loss.

---

Q: Is Gelaspan 4% used during major surgery?

Official documents describe its use for the management of low blood pressure associated with significant anticipated blood loss in a surgical setting. It is also indicated for use in certain procedures involving extracorporeal circulation (such as the heart-lung machine).

---

Q: Is it true that Gelaspan 4% is not used as a permanent solution?

Official information describes Gelaspan 4% as a treatment for acute volume replacement and restoration, for conditions such as shock. Its clinical role is therefore focused on temporary, acute clinical needs rather than long-term or chronic fluid management.

---

Q: What is the difference between Gelaspan 4% and saline solution?

Gelaspan 4% is classified as a colloid, which is a plasma volume substitute, while saline is a crystalloid solution. Regulatory cautions state that Gelaspan, a colloid, should only be used in situations where low blood volume cannot be treated sufficiently with crystalloids alone.

---

Q: Can Gelaspan 4% be used alongside other IV fluids?

Official prescribing information indicates that Gelaspan 4% should not be mixed with other medicinal products in the same infusion bag or line due to a lack of compatibility data. However, it can be used in combination with other IV fluids, such as crystalloid solutions, as long as they are administered separately.

---

Q: Does Gelaspan 4% interact with blood thinners?

Official safety warnings note that administering large doses of the solution can dilute coagulation factors, which are necessary for blood clotting. Official information emphasizes that careful monitoring is relevant for patients who have existing major blood coagulation disorders.

---

Q: Why might a doctor choose Gelaspan 4% instead of blood products?

Gelaspan 4% is used as a volume substitute when simple crystalloid solutions are not enough to restore circulating volume. It can be administered quickly to stabilize the patient during acute volume loss. Regulatory documents indicate that it is intended to replace lost fluid and can be used until a blood transfusion becomes necessary or available.

---

Q: Can Gelaspan 4% be used in patients with liver disease?

According to official prescribing information, Gelaspan 4% can be indicated for hypovolaemic patients who have liver disease, specifically because the formulation is lactate-free. However, the regulatory documentation advises that special care and careful dosage adjustments are necessary for all patients with chronic liver disease.

---

Q: Is the research for Gelaspan 4% considered strong?

Regulatory reviews confirm that Gelaspan is an established plasma volume substitute for adults. Official bodies have clinically reviewed the safety and efficacy data supporting its primary indications, such as volume replacement. However, official information does note that data is still limited regarding safety and effectiveness in the paediatric population.

---

Q: How is Gelaspan 4% prepared before infusion?

Before administration, the solution must be checked to ensure it is clear and free from any visible particles. Official documents state that if the infusion is administered rapidly, the solution may be warmed to no more than 37 C to help mitigate the risk of hypothermia.

---

Q: What does the term 'volume replacement' mean in the context of Gelaspan 4%?

In the context of Gelaspan 4%, volume replacement means the process of replacing lost fluid in the body’s blood vessels, known as circulating blood volume. Official information states this is necessary following events such as an operation, accident, or burn.

---

Q: What is the shelf life of Gelaspan 4% solution?

Official regulatory documents specify that the unopened product has a shelf life of 2 years from the date of manufacture. As Gelaspan 4% is a single-use solution, administration is typically initiated immediately once the container is opened. Any contents remaining after use are typically discarded.

---

Q: Does Gelaspan 4% affect urine output?

The official pharmacokinetic profile indicates that the majority of the administered solution is eliminated from the body via the kidneys. For this reason, official monitoring during use includes regularly checking the patient's water balance and urine output, especially for those with severe kidney issues.

---

Q: Is Gelaspan 4% used for blood loss from trauma?

Official patient information confirms that Gelaspan 4% is used to replace lost blood and body fluid following events such as an operation or an accident, which encompasses trauma. It is also indicated for fluid loss from burns.

How to Store and Dispose of Gelaspan 4% Solution

Official regulatory documents define specific conditions for the storage and disposal of Gelaspan 4% solution for infusion.

Storage Requirements

• Temperature Restrictions: The product must not be stored above 25 C and must be protected from freezing.
• Container Integrity: Gelaspan 4% should be kept in its original packaging until the time of use. The solution must be clear and free of any visible particles or precipitation before administration. Do not use the solution if the container is damaged.
• Child Safety: Like all medicines, Gelaspan 4% must be kept out of the reach and sight of children.
• In-Use Stability: The solution is for single use only. Once the container is opened, the infusion must be started immediately, and any unused contents must be discarded.

Disposal Instructions

Unused or expired Gelaspan 4% solution and related waste material must be disposed of according to local regulatory requirements. It is prohibited to dispose of the product in drains, wastewater, or household sewerage systems.